Literature DB >> 25877674

Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.

Wael El-Matary1,2, Karine Dupuis1, AbdulRazaq Sokoro3.   

Abstract

AIM: The role of noninvasive biologic markers for disease activity is very important in children with Crohn's disease. The aim of this study was to assess an association between disease activity and quantitative serum anti-Saccharomyces cerevisiae antibody (ASCA) titres.
METHODS: Anti-Saccharomyces cerevisiae antibody immunoglobulin (Ig) A and immunoglobulin G titres, paediatric Crohn's disease activity index (PCDAI), serum albumin and C-reactive protein (CRP) were repeatedly measured simultaneously in children with Crohn's disease. A possible association between ASCA IgA and IgG titres and changes in PCDAI was examined.
RESULTS: Serial 136 measurements of ASCA IgA and IgG titres were documented in 57 children with Crohn's disease over a mean duration of 3.1 ± 2.1 years. In a univariate linear regression model, there were significant correlations between ASCA IgA titres and PCDAI (p < 0.001), CRP (p <0.01) and low serum albumin (p < 0.001), respectively. Similarly, ASCA IgG titres significantly correlated with PCDAI, CRP and low serum albumin.
CONCLUSION: Both ASCA IgA and IgG titres seemed to correlate well with clinical Crohn's disease activity in children. Measuring these antibodies may be considered during routine clinical care for those patients. ©2015 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Anti-Saccharomyces cerevisiae; Antibodies; Colitis; Crohn's disease; Inflammatory bowel disease

Mesh:

Substances:

Year:  2015        PMID: 25877674     DOI: 10.1111/apa.13026

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Antibodies to Crohn's disease peptide 353 as a diagnostic marker for pediatric Crohn's disease: a prospective multicenter study in Japan.

Authors:  Tatsuki Mizuochi; Katsuhiro Arai; Takahiro Kudo; Ryusuke Nambu; Hitoshi Tajiri; Tomoki Aomatsu; Naoki Abe; Toshihiko Kakiuchi; Kunio Hashimoto; Tsuyoshi Sogo; Michiko Takahashi; Yuri Etani; Yugo Takaki; Ken-Ichiro Konishi; Jun Ishihara; Hitoshi Obara; Tatsuyuki Kakuma; Shunsuke Kurei; Yushiro Yamashita; Keiichi Mitsuyama
Journal:  J Gastroenterol       Date:  2020-01-24       Impact factor: 7.527

2.  Role of environmental factors in the pathogenesis of Crohn's disease: a critical review.

Authors:  Yueying Chen; Yining Wang; Jun Shen
Journal:  Int J Colorectal Dis       Date:  2019-11-16       Impact factor: 2.571

3.  Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease.

Authors:  Wael El-Matary; Esmail Abej; Vini Deora; Harminder Singh; Charles N Bernstein
Journal:  Front Pediatr       Date:  2017-01-25       Impact factor: 3.418

4.  A snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study.

Authors:  Camila Ortiz Prospero Cavalcante Costa; Flair José Carrilho; Valeria Sutti Nunes; Aytan Miranda Sipahi; Maraci Rodrigues
Journal:  BMC Gastroenterol       Date:  2015-12-08       Impact factor: 3.067

5.  Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn's Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage.

Authors:  Mi Jin Kim; Eunsil Kim; Ben Kang; Yoon Lee; Eun-Suk Kang; Yon Ho Choe
Journal:  Gut Liver       Date:  2021-09-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.